These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 8332149

  • 21. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ, Mann DE, Reiffel JE, Hahn E, Hartz V.
    Circulation; 1995 Apr 01; 91(7):1988-95. PubMed ID: 7895357
    [Abstract] [Full Text] [Related]

  • 22. Management of ventricular arrhythmias.
    Aronow WS.
    Compr Ther; 1988 Aug 01; 14(8):25-30. PubMed ID: 3048863
    [Abstract] [Full Text] [Related]

  • 23. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators.
    Circulation; 1989 Jun 01; 79(6):1354-60. PubMed ID: 2655967
    [Abstract] [Full Text] [Related]

  • 24. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ, Karagounis LA, Mann DE, Reiffel JA, Hahn E, Hartz V.
    Am J Cardiol; 1997 Feb 01; 79(3):315-22. PubMed ID: 9036751
    [Abstract] [Full Text] [Related]

  • 25. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G, Greene HL.
    Prog Cardiovasc Dis; 1996 Feb 01; 38(6):419-28. PubMed ID: 8638023
    [Abstract] [Full Text] [Related]

  • 26. Electrical alternans and vulnerability to ventricular arrhythmias.
    Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ.
    N Engl J Med; 1994 Jan 27; 330(4):235-41. PubMed ID: 8272084
    [Abstract] [Full Text] [Related]

  • 27. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome.
    Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN.
    N Engl J Med; 1988 Jan 07; 318(1):19-24. PubMed ID: 3336381
    [Abstract] [Full Text] [Related]

  • 28. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy.
    Ruskin JN, DiMarco JP, Garan H.
    N Engl J Med; 1980 Sep 11; 303(11):607-13. PubMed ID: 6772952
    [Abstract] [Full Text] [Related]

  • 29. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiffel JA, Hahn E, Hartz V, Reiter MJ.
    Am J Cardiol; 1997 Apr 15; 79(8):1048-53. PubMed ID: 9114762
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D, Dabrowski R, Szwed H, Gasior Z, Stanke A, Jasek S, Skrabucha B, Matar A, Kowalik I.
    Pol Merkur Lekarski; 1997 Feb 15; 2(8):122-5. PubMed ID: 9538657
    [Abstract] [Full Text] [Related]

  • 31. Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM trial).
    Olshansky B, Hartz V, Hahn E, Mason J, Weaver MD, ESVEM Investigators.
    Am J Cardiol; 2000 Oct 15; 86(8):846-51. PubMed ID: 11024399
    [Abstract] [Full Text] [Related]

  • 32. Can the electrophysiologic study predict treatment outcome in patients with sustained ventricular tachyarrhythmias unrelated to coronary artery disease?
    Davis LM, Cooper MJ, Sadick N, Byth K, Uther JB, Richards DA, Ross DL.
    Int J Cardiol; 1994 Jun 01; 45(1):53-68. PubMed ID: 7995663
    [Abstract] [Full Text] [Related]

  • 33. The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in children with premature beats: a randomized controlled pilot trial.
    Makarov L, Balykova L, Soldatova O, Komolyatova V, Serebruany V.
    Am J Ther; 2010 Jun 01; 17(4):396-401. PubMed ID: 19487925
    [Abstract] [Full Text] [Related]

  • 34. Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs.
    Mason JW, Winkle RA.
    N Engl J Med; 1980 Nov 06; 303(19):1073-7. PubMed ID: 7421912
    [Abstract] [Full Text] [Related]

  • 35. Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators.
    Circulation; 1993 Feb 06; 87(2):323-9. PubMed ID: 8425281
    [Abstract] [Full Text] [Related]

  • 36. Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
    Lazzara R.
    Pacing Clin Electrophysiol; 1994 Mar 06; 17(3 Pt 2):473-7. PubMed ID: 7513876
    [Abstract] [Full Text] [Related]

  • 37. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jan 06; 33(1):46-52. PubMed ID: 9935007
    [Abstract] [Full Text] [Related]

  • 38. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram.
    Anderson KP, Bigger JT, Freedman RA.
    Prog Cardiovasc Dis; 1996 Jan 06; 38(6):463-88. PubMed ID: 8638028
    [Abstract] [Full Text] [Related]

  • 39. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
    Steinbeck G, Andresen D, von Leitner ER.
    Z Kardiol; 1986 Jan 06; 75 Suppl 5():47-55. PubMed ID: 2435071
    [Abstract] [Full Text] [Related]

  • 40. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
    Reiffel JA, Reiter MJ, Freedman RA, Mann D, Huang SK, Hahn E, Hartz V, Mason J, ESVEM Investigators.
    Prog Cardiovasc Dis; 1996 Jan 06; 38(5):359-70. PubMed ID: 8604440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.